# HA Residents With PVD, Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) With and Without Supplemental Oxygen Therapy (SOT)

> **NCT06084559** · NA · UNKNOWN · sponsor: **University of Zurich** · enrollment: 24 (estimated)

## Conditions studied

- Pulmonary Vascular Disorder
- Pulmonary Artery Hypertension
- Chronic Thromboembolic Pulmonary Hypertension

## Interventions

- **OTHER:** Supplemental oxygen therapy
- **OTHER:** Sham Oxygen therapy

## Key facts

- **NCT ID:** NCT06084559
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-05
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2023-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06084559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06084559, "HA Residents With PVD, Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) With and Without Supplemental Oxygen Therapy (SOT)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06084559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*